TipRanks on MSN

Upcoming Stock Splits This Week (December 1 to December 5) – Stay Invested

These are the upcoming stock splits for the week of December 1 to December 5, based on TipRanks’ Stock Splits Calendar. A ...
The Manila Times

Cuprina Holdings (Cayman) Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) ('Cuprina” or 'the Company”), a biomedical company developing and marketing products for the chronic wounds, infertility, and cosmeceuticals sectors, ...
TipRanks on MSN

Cuprina Holdings receives noncompliance notification from Nasdaq

Cuprina Holdings (CUPR) received a letter of noncompliance from The Nasdaq Stock Market, dated November 26, 2025, notifying the Company that based ...

Stock Split Watch: Is ASML Next?

ASML has undergone four stock splits in its public life, with the most recent being an 8-to-9 split in October 2007. While ...

1 No-Brainer Stock-Split Stock to Buy Before the End of the Year, and 1 That Investors Would Be Wise to Avoid

Among Netflix, O'Reilly Automotive, Interactive Brokers, Fastenal, and Lucid Group, there's a company with undeniable ...

This Stock-Split Stock Is Up 88,600% Since Its IPO -- and Wall Street Thinks It's a Buy Right Now

Although some might worry about Netflix's valuation and acquisitions, the stock appears to be a good pick right now. 10 ...

Tile Shop Announces Special Meeting Results, Stock Split Ratio and Intention to Delist from Nasdaq

Following the approval of the Company’s stockholders at the Special Meeting, the Company’s Board of Directors approved a ratio of 1-for-3,000 for the Reverse Stock Split followed immediately by a ...

Tilray Plunges Ahead of a 1-for-10 Reverse Stock Split. Here's What You Need to Know

Tilray Brands shares tumbled Friday ahead of a reverse stock split set set to take effect after markets close next Monday, ...

Sutro Biopharma Announces 1-for-10 Reverse Stock Split

Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that its Board ...